Buradasınız

Anasayfa » Content

ŞİŞMAN KADINLARDA VİSERAL YAĞ İNDEKSİ VE METABOLİK RİSK GÖSTERGELERİ İLE İLİŞKİSİ

Value of visseral fat index as a predictor of cardiovascular risk status in obese women

Journal Name:

  • İstanbul Tıp Fakültesi Dergisi

Publication Year:

  • 1999

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
The aim of this study is to evaluate the relationship betvveen visseral fat İndex (VFI) and risk factors in obese (body mass index > 27 mg/m2) women. Study group is consisted of-1565 obese vvomen. Significant correlations were observed bctween VFI and cholesterol (r=0.1230), tryglyceridc (r-0.2826), HDL-chofestcrol (r=0.Û836), systolic bîood pressure (r=0.4166), di-astolic blood pressure (r=0.4367), uric acid (r=1886), glucose (r=0.1849), log insülin (r=2856), log HOMA (r-0.2699), BMI (r=0.8182), waist-hip ratio (r=0.6527) and vvaist circumference (r-0.9982) levels (p for HDL-cholesterol 0.0068, for others 0.0001). VFI was significantly higher in subjects with hypercholesterolemia ıhan that found in normocholesterolcmics (47.46+6.24 and 45.96±6.06, respectively), in subjects with hypertriglyceridemia than that found İn normotriglyceridemis (49.59+6.75 and 45.95+5.79, respectively), İn subjects with hypertension tiıan that found İn normotensives (48.94+6.32 and 44.63+4.99, respectively), in subjects with diabetes mellitus than that found in normoglycemİcs (51.53±5.76 and 46.45±6.I1, respectively), in subjects with hyperuricemia than that found in normourİccmia (49.59+6.54 and 46.32±6.08, respetively), in subjects with hyperinsulinemia than that found normomsulİnemia (47,97+6.18 and 45.55±5.65, respectively), and in subjects with lowcr HDL-cholesterol levels that found in normal HDL-cholesteroîemia (47,11+6.05 and 46.30+6.37, respectively) (p valucs for HDL-cholesteol 0.037, and others 0.001). It İs conelu-ded that VFI might be used for defermining visceral obesity associated with metabolic abnor-malities that most of them are cardiovascular risk factors.
Bookmark/Search this post with
Abstract (Original Language): 
Bu çalışma şişman kadınlarda vİseral yağ indeksi ("visceral fat index", VFI) ile çeşitli kardiyo-vasküler risk faktörleri arasındaki ilişkileri araştırmak amacıyla yapıldı. Çalışma kapsamına 1566 şişman (vücut kitle indeksi, BMI> 27 kg/m2) kadın alındı. Hastalarda VFI ile kolesterol (r=0.I230), trigliseriL (r=0.2826), HDL-kolesterol (r= 0.0836), maksimum damar basıncı (r= 0.4166), minimum damar basıncı (r= 0.4367), ürik asit (ı- 0,1886), glukoz (n= 1849), log insü-liii (r= 0.2856), log HOMA (r=0.2699), BMI (r=0.8182), bel/kaiça oranı (WHR, r=0.6527) vc bel çevresi (r=0.9982) arastnda anlamlı ilişkiler saptanmadı (p HDL-kolesterol için 0.0068, diğerleri 0.0001), VFI, kolesterol {47.45+6.24 ve 45.69+6.06), trigliserit (49.59+6.75 ve 45.95+5.79), damar basıncı (48.94±6.32 ve 44.63+4.99), glukoz (51.53+5.76 ve 46.45±6.11), ürik asit (49.59+6.54 ve 46.32+6.08) ve insülin (47.97+6.18 ve 45.55±5.65) düzeyi yüksek olanlarda v HDL-kolesterol düzeyi düşük olanlarda (47.11 ±6.05 ve 46.30±6.37) normal olanlara göre yüksek bulundu (p değeri HDL-kolesterol 0.037, diğerleri için 0.001). VFI, çeşitli risk gruplarında yüksek bulunmakta ve insülin direnci ile İlişki göstermektedir. Bu nedenle VFI nin risk taşıyan viseral şişman hastaların saptanmasında yararlı olabileceği düşünülmektedir.
FULL TEXT (PDF): 
PDF icon arastirmax-sisman-kadinlarda-viseral-yag-indeksi-metabolik-risk-gostergeleri-ile-iliskisi.pdf
  • 3
311-314
  • Turkish

REFERENCES

References: 

1. Armitage P, Berry G:Stau'slical-Methods-in-Medical Re-
search, Blackweîl, Oxford, 2. Baskı (1987).
2. Ashwell M, Chinn S, Slalley S, Garrow JS: Female fat distribution. A photographic and cellularity study. Int J Obes 2:289 (1978).
3. Ashwell M, Cole TJ, Dixon AK: New insight into the antropomctric classification of fat distribution by compu-ted tomography. BrMed J 290:1672 (1985).
4. Berger M: Risk of obesiy in typc II diabetes mellitus. Int J Obesity 16 (Sııppl 4): S29-S33 (1992).
5. CoIHns S, Surwith RS: Pharmacologic manipulation of ob exprcssion in a dietary model of obesity. J Biol Chem 271:9437(1996).
6. Despres JP, Prudhomme D, Pouliot MC, Trcmblay A, Bouchhard C:Estimalion of deep abdominal adİpose lis-sue accumuîation from simple antropometric measure-ments in men. Am J Clin Nutr 54:471 (1991).
7. Fonlbonne A, Papoz L, Eschvvegc E, Roger M, Saint-Pa-nl M, Simon D: Features of insülin resistance syndrome in men from Frencb Caribbean lsland. The Telecom Study. Diabetes 41:1385 (1992).
8. Haffner SM, Stern MP, Hazada HP, Pugh J, Patterson, JK: Do upper body and centralized adiposity measure
different aspects of rcgional body fat distribution. Relati-onship to non-insulin dcpemienl diabetes mellitus, lipid and lipoproteins. Diabetes 36:43 (11987).
9. Hartz AJ, Rupley DC, KalkhotT RD, Rimm AA: Relati-onship of obesity to diabetes. Influence of obesity leve] and body fat distribution. Prev Med 12:351 (1983).
10. Houmard JA, Wheeler WS, McCammon MR, Well JM, Tnıitt N, Isracl RG, Barakat HA: An evaluation of waist to hip ration measurement methods in relation to lipid and carbonhydrate metaboüsm in men. Int J Obes 15:181 (1991).
11. Kaplan NM: The deadly quartet. Upper body obesity, glucose introleranee, hyperlriglyceridemia and hypertcn-sion. Aım Intern Med 149:1514 (1989).
12. Kissebalı AH, Vydelingum N, Murray E, Evans D), Hartz AJ, Kalkhoff RK, Adatns PW: Relation of body fat distribution to metaboiic complications of obesity. J Clin Endocrinol Metab 54:254 (1992).
13. Krotkiewski M, Bjömtorp P, Sjöstrom L, Smith U: Im-pact of obesity on melabolism in men and women. J Clin Invest 72:1150(1983).
14. Lean MEJ, Han TS, Morrison CE: Waist circumference as a measure for indicating need for weight management. BrMedJ311:158 (1995).
15. MaUhews DR, Hosker JP, Rudcnski AS, Naylor BA, Treachcr DF, Tumer RC: Homeostasİs model assestnent: Insulin resistance and beta-cell funetion from fasting plasma glacose and insıılin concentrations in man. Dia-betologia 28:412 (1985).
16. Mortogiou A, Kapantais E, Valsamidis S, Chrisochoou D,_Oraiopolu_A:...Visceral.fat mdex.(VFI)._A.ne.w.clinical...
approarch of abdominal obesity. Int J Obesity 17 (suppl 2): 22(1993).
17. Nie NH, Hull CM, Jenkins JG, Steinbrennar K, Benta DM: Statistical Package of the Social Sciences, McGraw mil,'New York, 2. Baskı, (1975).
18. Norusis MJ: SPSS/PC+for the IBM PC/XT/AT. BPBB Inc.Chiago, (1986).
19. Reaven GM: Role of insülin in human disease. Diabetes 37:1595 (1988).
20. Seidell JC, Bjöntorp P, Sjöstrom L, Sannerstedt R, Kro-kiewski M, Kvist H: Regional dstribution of muscle fat mass in men. New insight into the risk of abdominal obesity using computed tomography. In J Obes 13:289 (1989).
21. Seidell JC, Oosterlce A, Deudenberg P, Hautvast JGAJ, Rujiz JHJ: Abdominal fat depots measured with computed tomography. Effects of degree of obesity, sex and agc. EurJ Clin Nu£r 42:805 (1988).
22. Williams MJ, Hunter GR, Kekes-Szabo T, Trueth MS, Synder S, Berland I, Blaudeau T: Inlra-abdominal adipo-se tissue cut-points related to elevated cardiovascular risk in women. Int J Obesity 20:613 (1996).

Thank you for copying data from http://www.arastirmax.com